Persistence of onchocerciasis in villages in Enugu and Ogun states in Nigeria following many rounds of mass distribution of ivermectin

Abstract Background Onchocerciasis is endemic in most local government areas (LGAs) in Enugu and Ogun states. Most meso- and hyper-endemic LGAs have received many rounds of ivermectin mass drug administration (MDA). This study aimed to determine the current prevalence of onchocerciasis in villages i...

Full description

Bibliographic Details
Main Authors: Uwem F. Ekpo, Obiora A. Eneanya, Edith N. Nwankwo, Islamiat Y. Soneye, Gary J. Weil, Peter U. Fischer, Obioma C. Nwaorgu
Format: Article
Language:English
Published: BMC 2022-11-01
Series:BMC Infectious Diseases
Subjects:
Online Access:https://doi.org/10.1186/s12879-022-07811-7
_version_ 1828098562094792704
author Uwem F. Ekpo
Obiora A. Eneanya
Edith N. Nwankwo
Islamiat Y. Soneye
Gary J. Weil
Peter U. Fischer
Obioma C. Nwaorgu
author_facet Uwem F. Ekpo
Obiora A. Eneanya
Edith N. Nwankwo
Islamiat Y. Soneye
Gary J. Weil
Peter U. Fischer
Obioma C. Nwaorgu
author_sort Uwem F. Ekpo
collection DOAJ
description Abstract Background Onchocerciasis is endemic in most local government areas (LGAs) in Enugu and Ogun states. Most meso- and hyper-endemic LGAs have received many rounds of ivermectin mass drug administration (MDA). This study aimed to determine the current prevalence of onchocerciasis in villages in Enugu and Ogun states that were formerly highly endemic and to assess progress toward elimination of the infection in areas believed to be at high risk for persistence. Methods Cross-sectional community surveys were conducted 8 to 12 months after the last round of MDA in 16 villages (6 in Enugu state and 10 in Ogun state) in individuals aged ≥ 18 years. Study participants were examined for the presence of palpable subcutaneous nodules. Skin snips from the posterior iliac crests were used to assess microfiladermia (Mf) prevalence and density. Results 643 subjects were palpated for nodules and 627 individuals (225 in Enugu state; 402 in Ogun state) provided skin snips. Nodule prevalence in the study villages ranged from 42 to 66.7% in Enugu state and from 0 to 25.0% in Ogun state. Mf prevalence in the Enugu and Ogun study villages ranged from 32 to 51.1% and 0 to 28.6%, respectively. Geometric mean skin Mf density in surveyed Enugu state villages ranged between 1 and 3.1 Mf/mg; these values were < 1 Mf/mg in all but one community in Ogun state villages. Conclusion Results from this study show that onchocerciasis persists in adults in many villages in Enugu and Ogun states despite many prior rounds of ivermectin MDA. Prevalence was higher in villages surveyed in Enugu than in Ogun. Low Mf densities suggest the MDA program is working well to reduce disease, but more time will be required to reach the elimination goal.
first_indexed 2024-04-11T08:04:17Z
format Article
id doaj.art-f1c096a0e0d44745b9a3d9c1aa32e245
institution Directory Open Access Journal
issn 1471-2334
language English
last_indexed 2024-04-11T08:04:17Z
publishDate 2022-11-01
publisher BMC
record_format Article
series BMC Infectious Diseases
spelling doaj.art-f1c096a0e0d44745b9a3d9c1aa32e2452022-12-22T04:35:38ZengBMCBMC Infectious Diseases1471-23342022-11-012211610.1186/s12879-022-07811-7Persistence of onchocerciasis in villages in Enugu and Ogun states in Nigeria following many rounds of mass distribution of ivermectinUwem F. Ekpo0Obiora A. Eneanya1Edith N. Nwankwo2Islamiat Y. Soneye3Gary J. Weil4Peter U. Fischer5Obioma C. Nwaorgu6Department of Pure and Applied Zoology, Federal University of AgricultureInfectious Diseases Division, Washington University School of MedicineDepartment of Parasitology and Entomology, Faculty of Biosciences, Nnamdi Azikiwe UniversityNeglected Tropical Disease Control Unit, Ogun State Ministry of HealthInfectious Diseases Division, Washington University School of MedicineInfectious Diseases Division, Washington University School of MedicineDepartment of Parasitology and Entomology, Faculty of Biosciences, Nnamdi Azikiwe UniversityAbstract Background Onchocerciasis is endemic in most local government areas (LGAs) in Enugu and Ogun states. Most meso- and hyper-endemic LGAs have received many rounds of ivermectin mass drug administration (MDA). This study aimed to determine the current prevalence of onchocerciasis in villages in Enugu and Ogun states that were formerly highly endemic and to assess progress toward elimination of the infection in areas believed to be at high risk for persistence. Methods Cross-sectional community surveys were conducted 8 to 12 months after the last round of MDA in 16 villages (6 in Enugu state and 10 in Ogun state) in individuals aged ≥ 18 years. Study participants were examined for the presence of palpable subcutaneous nodules. Skin snips from the posterior iliac crests were used to assess microfiladermia (Mf) prevalence and density. Results 643 subjects were palpated for nodules and 627 individuals (225 in Enugu state; 402 in Ogun state) provided skin snips. Nodule prevalence in the study villages ranged from 42 to 66.7% in Enugu state and from 0 to 25.0% in Ogun state. Mf prevalence in the Enugu and Ogun study villages ranged from 32 to 51.1% and 0 to 28.6%, respectively. Geometric mean skin Mf density in surveyed Enugu state villages ranged between 1 and 3.1 Mf/mg; these values were < 1 Mf/mg in all but one community in Ogun state villages. Conclusion Results from this study show that onchocerciasis persists in adults in many villages in Enugu and Ogun states despite many prior rounds of ivermectin MDA. Prevalence was higher in villages surveyed in Enugu than in Ogun. Low Mf densities suggest the MDA program is working well to reduce disease, but more time will be required to reach the elimination goal.https://doi.org/10.1186/s12879-022-07811-7OnchocerciasisIvermectinMass drug administrationNigeria
spellingShingle Uwem F. Ekpo
Obiora A. Eneanya
Edith N. Nwankwo
Islamiat Y. Soneye
Gary J. Weil
Peter U. Fischer
Obioma C. Nwaorgu
Persistence of onchocerciasis in villages in Enugu and Ogun states in Nigeria following many rounds of mass distribution of ivermectin
BMC Infectious Diseases
Onchocerciasis
Ivermectin
Mass drug administration
Nigeria
title Persistence of onchocerciasis in villages in Enugu and Ogun states in Nigeria following many rounds of mass distribution of ivermectin
title_full Persistence of onchocerciasis in villages in Enugu and Ogun states in Nigeria following many rounds of mass distribution of ivermectin
title_fullStr Persistence of onchocerciasis in villages in Enugu and Ogun states in Nigeria following many rounds of mass distribution of ivermectin
title_full_unstemmed Persistence of onchocerciasis in villages in Enugu and Ogun states in Nigeria following many rounds of mass distribution of ivermectin
title_short Persistence of onchocerciasis in villages in Enugu and Ogun states in Nigeria following many rounds of mass distribution of ivermectin
title_sort persistence of onchocerciasis in villages in enugu and ogun states in nigeria following many rounds of mass distribution of ivermectin
topic Onchocerciasis
Ivermectin
Mass drug administration
Nigeria
url https://doi.org/10.1186/s12879-022-07811-7
work_keys_str_mv AT uwemfekpo persistenceofonchocerciasisinvillagesinenuguandogunstatesinnigeriafollowingmanyroundsofmassdistributionofivermectin
AT obioraaeneanya persistenceofonchocerciasisinvillagesinenuguandogunstatesinnigeriafollowingmanyroundsofmassdistributionofivermectin
AT edithnnwankwo persistenceofonchocerciasisinvillagesinenuguandogunstatesinnigeriafollowingmanyroundsofmassdistributionofivermectin
AT islamiatysoneye persistenceofonchocerciasisinvillagesinenuguandogunstatesinnigeriafollowingmanyroundsofmassdistributionofivermectin
AT garyjweil persistenceofonchocerciasisinvillagesinenuguandogunstatesinnigeriafollowingmanyroundsofmassdistributionofivermectin
AT peterufischer persistenceofonchocerciasisinvillagesinenuguandogunstatesinnigeriafollowingmanyroundsofmassdistributionofivermectin
AT obiomacnwaorgu persistenceofonchocerciasisinvillagesinenuguandogunstatesinnigeriafollowingmanyroundsofmassdistributionofivermectin